Two studies were from refugee camps in South Sudan and the African region, Gargano et al. and Reardon et al., and supported the cost-effectiveness of hepatitis B vaccination, either in conjunction with routine immunization or pneumonia immunization [24, 25]. This evidence concerns the gene PPIB and hepatitis A virus infection.